Hoffmann-La Roche: all 2,744 studies
Page 26 of 28. Open to participants first (117), then studies with results posted, then the rest; newest registration first within each.
- A Study of PRO95780 in Combination With Rituximab in Patients With Non-Hodgkin's Lymphoma That Has Progressed Following Previous Rituximab Therapy (APM4083g)CompletedNCT00517049Phase 2
- Safety Study in Subjects With Leber Congenital AmaurosisCompletedNCT00516477Phase 1
- LTFU for Gene Transfer Subjects With Hemophilia BCompletedNCT00515710
- A Study of R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis.CompletedNCT00504270Phase 2
- A Study of Loading Doses of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Malignant Bone Disease.CompletedNCT00502736Phase 2
- A Study of Dipeptidyl-peptidase IV (DPP-IV) RO4876904 in Patients With Type 2 Diabetes.CompletedNCT00502710Phase 2
- A Study of PRO95780 in Combination With Cetuximab and Irinotecan Chemotherapy or the FOLFIRI Regimen With Bevacizumab in Patients With Previously Treated Metastatic Colorectal Cancer (APM4187g)CompletedNCT00497497Phase 1
- Efficacy Study With 500 mg QD of TRO19622 vs Placebo in Patients With Painful Peripheral Diabetic NeuropathyCompletedNCT00496457Phase 2
- A Trial of the Safety of Escalating Doses of PRO131921 in Patients With Relapsed or Refractory Chronic Lymphocytic LeukemiaTerminatedNCT00496132Phase 1/2
- BONDIR Study: A Study of Intravenous Bonviva (Ibandronate) After Recent Vertebral Osteoporotic Fracture in Patients With Osteoporosis.CompletedNCT00493623Phase 3
- A Study of Quarterly Intravenous Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis.No longer availableNCT00493532
- A Multiple Ascending Dose Study of R1530 in Patients With Advanced Solid Tumors.CompletedNCT00493155Phase 1
- Clinical Study of R744 to Predialysis Patients( Phase III, Comparative Study in Comparison With Epoetin Beta)CompletedNCT00492427Phase 3
- Clinical Study of R744 to Hemodialysis PatientsCompletedNCT00491868Phase 3
- A Study of PRO95780 in Patients With Previously Untreated, Advanced-Stage Non-Small Cell Lung Cancer (APM4074g)CompletedNCT00480831Phase 2
- A Study of Loading Doses of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Metastatic Bone Disease.WithdrawnNCT00478270Phase 2
- A Study to Evaluate Corrected QT Interval From Clinical Studies Conducted With BevacizumabWithdrawnNCT00477425
- A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus Ribavirin in Hemophiliac Patients With Chronic Hepatitis C.CompletedNCT00475072Phase 4
- A Study Comparing Continuous Subcutaneous Insulin Infusion With Multiple Daily Injections With Insulin Lispro and GlargineCompletedNCT00468754Not applicable
- Postoperative Canadian Oral Anticoagulation Self-management (Post-COAGS) TrialWithdrawnNCT00468702Not applicable
- Phase Ⅱ Clinical Study of R435 (Bevacizumab) in Combination With Paclitaxel in Patients With Inoperable Metastatic Breast CancerCompletedNCT00467012Phase 2
- ESP Study: A Study to Assess the Effect of Adding Fuzeon (Enfuvirtide) to an Antiretroviral Regimen in Fuzeon-Naive Patients With Sustained HIV Viral Suppression.WithdrawnNCT00461266Phase 4
- A Comparative Study of Aleglitazar and Actos in Patients With Type 2 Diabetes Mellitus and New York Heart Association (NYHA) Class II Heart Failure.CompletedNCT00461058Phase 2
- A Comparison of the Effects of Aleglitazar and Actos on Renal Function on Patients With Type 2 Diabetes.CompletedNCT00461006Phase 2
- A Titration Study of a Glucagon-Like Peptide-1 (GLP-1) Analogue in Patients With Type 2 Diabetes Treated With Metformin.CompletedNCT00460941Phase 2
- A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With Lamivudine Resistant HBeAg-Negative Chronic Hepatitis B.TerminatedNCT00460850Phase 4
- A Trial of the Safety of Escalating Doses of PRO131921 in Patients With Relapsed or Refractory Indolent Non-Hodgkin's LymphomaTerminatedNCT00452127Phase 1/2
- Phase II/III Clinical Study of R484iv (Ibandronic Acid) for Primary OsteoporosisCompletedNCT00447915Phase 3
- A Study of the Safety of Rituxan in Patients With Rheumatoid Arthritis After an Inadequate Response to Previous Anti-TNF Therapy (SUNSTONE)CompletedNCT00443443
- A Study Comparing Mircera and Epoetin Beta for the Treatment of Anemia in Dialysis Patients With Chronic Kidney Disease.CompletedNCT00442793Phase 3
- A Study of NeoRecormon (Epoetin Beta) in Patients With Renal Anemia.TerminatedNCT00440063Phase 4
- A Study of Xeloda (Capecitabine) in Combination With XELOX (Oxaliplatin) in Patients With Metastatic Nasopharyngeal Cancer.CompletedNCT00439426Phase 2
- A Study of NeoRecormon in Patients With Chronic Kidney Disease.CompletedNCT00437723Phase 4
- A Study of Sequential Treatment With Daivobet (Betamethasone Dipropionate Plus Calcipotriol) and Daivonex (Calcipotriol) in Patients With Psoriasis.CompletedNCT00437619Phase 4
- A Study of the Pharmacokinetics/Pharmacodynamics of GK Activator (2) in Type 2 Diabetes Patients With Hepatic Impairment.TerminatedNCT00437606Phase 1
- A Study of Xeloda (Capecitabine) as First-Line Chemotherapy in Patients With Advanced or Metastatic Gastric Cancer.CompletedNCT00436241Phase 2
- A Study of Tamiflu (Oseltamivir) Treatment in Laboratory-Confirmed Influenza.TerminatedNCT00436124Phase 4
- Switch and Maintenance Study of Intravenous Injections of R744 to Hemodialysis Patients (Phase Ⅲ Study)CompletedNCT00433888Phase 3
- Clinical Study of R744 to Peritoneal Dialysis PatientsCompletedNCT00433849Phase 3
- Correction Study of R744 in Renal Anemia Patients on HemodialysisCompletedNCT00433693Phase 3
- Clinical Study of R744 to Predialysis PatientsCompletedNCT00433615Phase 3
- VICTOR Study - A Study of Valcyte (Valganciclovir po) Compared to Ganciclovir iv in Patients With Cytomegalovirus (CMV) Disease Who Are Solid Organ Transplant RecipientsCompletedNCT00431353Phase 4
- A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.CompletedNCT00423501Phase 2
- A Study of CellCept (Mycophenolate Mofetil) in Kidney Transplant Patients Switched From EC-MPS.TerminatedNCT00420472Phase 4
- TESRA: (Treatment of Emphysema With a Gamma-Selective Retinoid Agonist)CompletedNCT00413205Phase 2
- A Study of NeoRecormon (Epoetin Beta) in Patients With End Stage Renal Disease.CompletedNCT00413101Phase 4
- A Study of Tamiflu (Oseltamivir) for Seasonal Prophylaxis of Influenza in Children.CompletedNCT00412555Phase 4
- SYREN Study: A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus Copegus (Ribavirin) in Non-Responder Patients With Chronic Hepatitis C (CHC) Genotype 1.CompletedNCT00412334Phase 4
- A Continuation Study to Assess the Effect of CellCept in Patients With Myasthenia Gravis.CompletedNCT00408213Phase 3
- A Study to Evaluate the Safety and Efficacy of HAE1 in Subjects With Moderate to Severe Allergic AsthmaCompletedNCT00406965Phase 2
- A Study of Avastin (Bevacizumab) in Combination With Platinum-Based Chemotherapy in Patients With Advanced or Recurrent Squamous Non-Small Cell Lung CancerTerminatedNCT00404703Phase 2
- A Study to Evaluate the Safety of Rituximab Retreatment in Subjects With Lupus Nephritis Previously Enrolled in Study U2970gWithdrawnNCT00404157Phase 3
- A Study to Evaluate the Safety of Xolair in Moderate to Severe Persistent Asthma Patients (ALTO)CompletedNCT00401596Phase 3
- A Multiple Ascending Dose Study of R1507 in Patients With Advanced Solid Tumors.CompletedNCT00400361Phase 1
- A Study of R547 in Patients With Advanced Solid Tumors.CompletedNCT00400296Phase 1
- A Drug-Drug Interaction Study of GK Activator (2) and Glyburide in Patients With Type 2 Diabetes.CompletedNCT00388986Phase 1
- A Study of Aleglitazar in Patients With Type 2 DiabetesCompletedNCT00388518Phase 2
- A Study of Avastin in Combination With Chemotherapy for Treatment of Colorectal Cancer and Non-Small Cell Lung Cancer (ARIES)CompletedNCT00388206
- A Study to Evaluate the Effects of Efalizumab on Immune Responses in Subjects With Moderate Plaque PsoriasisCompletedNCT00382512Phase 1
- PhaseⅢOpen-label Study of MRA for Rheumatoid Arthritis(RA)CompletedNCT00380601Phase 3
- COMFORT Study: A Crossover Study of NeoRecormon (Epoetin Beta) and Darbepoetin Alfa in Patients With Renal Anemia.CompletedNCT00377481Phase 4
- A Drug-Drug Interaction Study of GK Activator (2) and Simvastatin in Patients With Type 2 Diabetes.CompletedNCT00377442Phase 1
- A Study of Hepatitis C Virus (HCV) Polymerase Inhibitor Pro-Drug in Combination With PEGASYS With or Without COPEGUS in Patients With Chronic Hepatitis C (CHC) Genotype 1 Infection.CompletedNCT00377182Phase 2
- An Observational Study of the Use and Safety of Xolair® During PregnancyCompletedNCT00373061
- A Study of the Effect of Renal Impairment on the Activity of GK Activator (2) in Patients With Type 2 Diabetes.CompletedNCT00368368Phase 1
- A Dose-Titration Study of GK Activator (2) in Patients With Type 2 Diabetes.CompletedNCT00366379Phase 2
- A Drug Interaction Study Between Tocilizumab, Methotrexate and Simvastatin on Patients With Rheumatoid Arthritis.CompletedNCT00365001Phase 1
- A Study of Mircera in Anemic Patients With Multiple MyelomaCompletedNCT00360347Phase 1/2
- A Study to Assess the Effect of Topical Recombinant Human Vascular Endothelial Growth Factor for Induction of Healing of Diabetic Foot UlcersCompletedNCT00351767Phase 2
- Clinical Study of Capecitabine, Oxaliplatin and Bevacizumab in Colorectal CancerCompletedNCT00345761Phase 1/2
- A Study to Evaluate Bevacizumab Alone or in Combination With Irinotecan for Treatment of Glioblastoma Multiforme (BRAIN)CompletedNCT00345163Phase 2
- A Study to Evaluate Efalizumab in Adults With Plaque Psoriasis, Including Those Who Are Receiving Concomitant Antipsoriatic TherapiesCompletedNCT00338143Phase 3
- A Study of the Safety and Efficacy of Tarceva in Patients With First Relapse of Grade IV Glioma (Glioblastoma Multiforme)CompletedNCT00337883Phase 2
- BOSS Study: A Study of Fuzeon Using the Needle-Free Biojector 2000 in Patients With HIV-1 InfectionCompletedNCT00337701Phase 4
- A Study of Epothilone D in Combination With Herceptin (Trastuzumab) in Patients With HER-2 Positive Advanced or Metastatic Breast CancerCompletedNCT00337649Phase 1/2
- Pharmacogenetic Study of CellCept (Mycophenolate Mofetil) in Kidney Transplant Patients.CompletedNCT00337493Phase 4
- A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving First Line Chemotherapy.CompletedNCT00327535Phase 2
- A Study of P38 Inhibitor (4) in Patients With Active Rheumatoid Arthritis (RA) on Stable Methotrexate TherapyCompletedNCT00316771Phase 2
- A Study to Evaluate the Long-Term Safety and Tolerability of GK Activator (2) in Patients With Type 2 Diabetes.CompletedNCT00316758Phase 2
- A Study to Evaluate the Safety and Efficacy of Efalizumab in Adult Patients With Plaque Psoriasis Involving the Hands and/or FeetCompletedNCT00312026Phase 4
- A Study to Determine the Variability of a 6-Minute Walk Test in Cystic Fibrosis Subjects With Advanced Lung DiseaseCompletedNCT00311506
- Cathflo Activase Pediatric StudyCompletedNCT00307580Phase 4
- A Study of Peginterferon Alfa-2a in Combination With Ribavirin in Chronic Hepatitis C (CHC) Patients With Compensated Liver Cirrhosis (LC)CompletedNCT00304551Phase 3
- A Study of Beta-Lactam in Hospitalized Patients With Skin and Skin Structure InfectionsCompletedNCT00303589Phase 2
- A Study of P38 Inhibitor (4) Monotherapy in Patients With Active Rheumatoid ArthritisCompletedNCT00303563Phase 2
- A Study of Intravenous INO-1001 Plus Oral Temozolomide to Evaluate Tolerability, Safety, and Pharmacokinetics in Patients With MelanomaTerminatedNCT00272415Phase 1
- A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of MetforminCompletedNCT00266253Phase 2
- A Study of GK Activator (2) in Patients With Type 2 Diabetes MellitusCompletedNCT00266240Phase 2
- A Study of Xolair to Evaluate Effectiveness and Long-Term Safety in Patients With Moderate to Severe AsthmaCompletedNCT00252135
- A Study to Evaluate Ranibizumab in Subjects With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)CompletedNCT00251459Phase 3
- Trial of Pegasys® in Patients With Chronic Hepatitis CCompletedNCT00245414Phase 4
- WAND Study - A Study to Evaluate Fuzeon (Enfuvirtide) Administered by a Needle-Free Injection Device in Patients With HIV.CompletedNCT00233883Phase 4
- QUALITE Study - A Study of Fuzeon (Enfuvirtide) in Treatment-Experienced Patients With Human Immunodeficiency Virus-1 (HIV-1) InfectionCompletedNCT00232908Phase 4
- A Study To Assess the Quality and Strength of Bone in Women Participants With Osteoporosis Taking Oral Ibandronate Versus PlaceboCompletedNCT00148915Phase 4
- Study of MRA for Polyarticular Juvenile Idiopathic Arthritis (pJIA)CompletedNCT00144664Phase 3
- Study of MRA in Patients With Rheumatoid Arthritis (RA)CompletedNCT00144651Phase 2
- Long-term Treatment Study of MRA for Polyarticular Juvenile Idiopathic Arthritis (pJIA)CompletedNCT00144625Phase 3
- Long-term Treatment Study of MRA for Systemic Juvenile Idiopathic Arthritis (sJIA)CompletedNCT00144612Phase 3
- Study of MRA for Systemic Juvenile Idiopathic Arthritis (sJIA)CompletedNCT00144599Phase 3
- Long-term Treatment Study of MRA for Rheumatoid Arthritis (RA) From Study MRA220JP or MRA221JPCompletedNCT00144586Phase 3